Indoco Remedies Ltd
NSE:INDOCO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Indoco Remedies Ltd
NSE:INDOCO
|
IN |
|
Castle Biosciences Inc
NASDAQ:CSTL
|
US |
|
BNP Paribas Bank Polska SA
F:82MA
|
PL |
|
A
|
Albireo Pharma Inc
F:BDQM
|
US |
|
OSB Group PLC
LSE:OSB
|
UK |
|
Newtek Business Services Corp
NASDAQ:NEWT
|
US |
|
M
|
Meritor Inc
F:AID1
|
US |
Wall Street
Price Targets
INDOCO Price Targets Summary
Indoco Remedies Ltd
According to Wall Street analysts, the average 1-year price target for
INDOCO
is 251.43 INR
with a low forecast of 224.22 INR and a high forecast of 288.75 INR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is INDOCO's stock price target?
Price Target
251.43
INR
According to Wall Street analysts, the average 1-year price target for
INDOCO
is 251.43 INR
with a low forecast of 224.22 INR and a high forecast of 288.75 INR.
What is Indoco Remedies Ltd's Revenue forecast?
Projected CAGR
12%
For the last 13 years the
compound annual growth rate for
Indoco Remedies Ltd's revenue is
9%.
The projected
CAGR
for the next 3 years is
12%.
